Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.
Forgot Your Password?
Your search returned 0 results, you might be interested in:
Follow Topic
Bookmark
Copy Link
The changes at least indicate ministers are taking a more pragmatic approach to Pharmacy First payment thresholds, says CPE.
15 Oct 2024 , 1 Min Article
Paul Rees played down concerns the NPA's work-to-rule strategy risks alienating the government.
14 Oct 2024 , 1 Min Article
CCA head of policy Nick Thayer said Pharmacy First had "arguably the most successful start to any national service across the UK."
Pharmacy First payment threshold will remain at 20 until 2025
Raylane Ltd, which operates in the West Midlands, Worcestershire, Gloucestershire and Staffordshire, bought Evans Pharmacy.
11 Oct 2024 , 1 Min Article
Director says he was 'entirely naive' when he and a friend set up an online pharmacy
The MHRA approved two “presentations of the adapted vaccine” after they met its standards of safety, quality, and effectiveness.
NHS Business Services Authority figures reveal there were 12,009 community pharmacies in 2023-24, 595 more than in 2022-23.
10 Oct 2024 , 1 Min Article
Group owner sells to husband and wife team after 30 years in business
Ian and Jas Riaar bought Wards Chemist in the village of Handsworth Wood in North Birmingham.
The National Pharmacy Association said NHSBSA double counted pharmacies and included “pharmacies that have shut their doors" in its figures.
The campaign focuses on workplace culture, loneliness and professional isolation and physical health.
09 Oct 2024 , 1 Min Article
Appetite strong for 'those businesses that can weather the storm' says property company
NICE consults on proposals to roll out GLP-1 receptor agonist to critical target groups
08 Oct 2024 , 1 Min Article
A new Repeat Prescribing Toolkit commissioned by NHS England which aims to streamline repeat prescribing systems and reduce medicines waste has been launched by the RPS and RCGP
Elafibranor (Iqirvo) has been approved by the MHRA to treat adult patients with a rare type of liver disease known as primary biliary cholangitis